|
| 36636840 | Targeting of a New Node in Lipid Metabolism as a Potential Treatment Strategy for ACC. | Endocrinology | 2023 |
| 37810891 | Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye disease. | Front Endocrinol (Lausanne) | 2023 |
| 37183548 | Novel Candidate Regulators and Developmental Trajectory of Pituitary Thyrotropes. | Endocrinology | 2023 |
| 37435490 | Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. | Front Endocrinol (Lausanne) | 2023 |
| 37129912 | β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer. | Cancer Res | 2023 |
| 35166237 | Bones and adrenal organogenesis: how embryonic osteocalcin influences lifelong adrenal function. | J Clin Invest | 2022 |
| 35551369 | Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies. | Endocr Rev | 2022 |
| 35976622 | American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. | JAMA Surg | 2022 |
| 33338548 | β-catenin in adrenal zonation and disease. | Mol Cell Endocrinol | 2021 |
| 33534120 | What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics. | Endocr Pathol | 2021 |
| 33058950 | Stem cell function and plasticity in the normal physiology of the adrenal cortex. | Mol Cell Endocrinol | 2021 |
| 32791542 | Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors. | Horm Metab Res | 2020 |
| 30475217 | Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism. | Endocr Relat Cancer | 2019 |
| 32258822 | New strategies for applying targeted therapies to adrenocortical carcinoma. | Curr Opin Endocr Metab Res | 2019 |
| 32258821 | Regulation of stem and progenitor cells in the adrenal cortex. | Curr Opin Endocr Metab Res | 2019 |
| 31220287 | Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma. | J Clin Endocrinol Metab | 2019 |
| 30770352 | Targeted Assessment of <i>G0S2</i> Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma. | Clin Cancer Res | 2019 |
| 30343951 | Longitudinal patterns of recurrence in patients with adrenocortical carcinoma. | Surgery | 2019 |
| 30692207 | A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis. | Genes Dev | 2019 |
| 29211850 | Sonic Hedgehog and WNT Signaling Promote Adrenal Gland Regeneration in Male Mice. | Endocrinology | 2018 |
| 30402590 | Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era. | J Endocr Soc | 2018 |
| 30346404 | Isolation, Fixation, and Immunofluorescence Imaging of Mouse Adrenal Glands. | J Vis Exp | 2018 |
| 30279954 | Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma. | Oncotarget | 2018 |
| 29625050 | Oncogenic Signaling Pathways in The Cancer Genome Atlas. | Cell | 2018 |
| 27940298 | Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia. | Mol Cell Endocrinol | 2017 |
| 28386245 | Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex. | Front Endocrinol (Lausanne) | 2017 |
| 28893949 | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | Development | 2017 |
| 28819017 | Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. | Eur J Endocrinol | 2017 |
| 26728468 | 5th International ACC Symposium: Introduction. | Horm Cancer | 2016 |
| 26678830 | Mouse models of adrenocortical tumors. | Mol Cell Endocrinol | 2016 |
| 27505681 | Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. | Cancer Cell | 2016 |
| 27165862 | Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations. | Eur J Endocrinol | 2016 |
| 27165744 | Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. | Cancer Cell | 2016 |
| 26750456 | Nutritional conditions regulate transcriptional activity of SF-1 by controlling sumoylation and ubiquitination. | Sci Rep | 2016 |
| 26986192 | ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs. | Endocrinology | 2016 |
| 26765578 | Molecular Heterogeneity in Aldosterone-Producing Adenomas. | J Clin Endocrinol Metab | 2016 |
| 26760044 | Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. | J Clin Endocrinol Metab | 2016 |
| 25287283 | Regulation of the adrenocortical stem cell niche: implications for disease. | Nat Rev Endocrinol | 2015 |
| 26038200 | Development of adrenal cortex zonation. | Endocrinol Metab Clin North Am | 2015 |
| 26021762 | Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer. | Horm Cancer | 2015 |
| 25668018 | Hedgehog signaling and steroidogenesis. | Annu Rev Physiol | 2015 |
| 25754631 | Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. | Int J Radiat Oncol Biol Phys | 2015 |
| 25795408 | Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. | Lancet Oncol | 2015 |
| 23848572 | An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome. | Clin Endocrinol (Oxf) | 2014 |
| 25029241 | Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. | Mol Endocrinol | 2014 |
| 24780050 | Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency. | J Clin Endocrinol Metab | 2014 |
| 24836548 | Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome. | Eur J Endocrinol | 2014 |
| 24763440 | Withanolides are potent novel targeted therapeutic agents against adrenocortical carcinomas. | World J Surg | 2014 |
| 24302750 | Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. | J Clin Endocrinol Metab | 2014 |
| 24423978 | Adrenocortical carcinoma. | Endocr Rev | 2014 |